A Phase 1b Trial to Evaluate Safety and Effect of SAR443122 on Immune System in Severe COVID-19

NCT04469621 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

68

Enrollment

INDUSTRY

Sponsor class

Conditions

Corona Virus Infection

Interventions

DRUG: SAR443122
DRUG: Placebo

Sponsor

Sanofi